Young and middle aged men often suffer from chronic prostatitis. About this problem as it is written popular books and articles, prostatitis is mentioned in almost all advertising “miracle” drugs and devices. The reason is simple, and, unfortunately, far from the medicine. Prostatitis – is a disease that has a man in every sense, from the waist down. It is often, though not always justified, linked with a decrease in potency. Therefore, the problem of suffering is so intimate and good target for commercial use. Who does not want to earn on the treatment of prostatitis even if men do not have it.
If we exclude the strong overcooling and running genital infections, the main cause of the disease will be stagnation in the prostate gland. In his younger years prostatitis begins to suffer notorious boys, shy acquainted with the girls, and, accordingly, do not lead a regular sex life. Their ranks are reluctant to replenish sailors and honest husbands on long trips. Thus, the main recommendation for the prevention and treatment of prostatitis is regular sex life with the frequency at which the body individually adjusted every man, according to age, hormonal activity and vital status at last.
The more we talk about prostatitis will not, as in old age, this problem even for those with whom she was out on the back burner. The vast majority of men over 50 – 60 years is beginning to suffer from benign prostatic hyperplasia (BPH). This disease is more known for the old term as BPH. We will use both names.
The first signs of BPH found in 8% of men aged 31 to 40 years. Then the frequency of this disease increases rapidly and reaches in men older than 70% in ’61 and more. After 90 years, the incidence of BPH can reach 90%. In the structure of the kidney and urinary tract to the share of the disease accounts for up to 74%. In prophylactic examination of men older than 50 years of BPH is found in 10-15% of cases, but the clinical manifestations of the disease are observed not all. Thus 80-85% of men older than 60 years and occurs in varying degrees of enlargement of the prostate gland.
Averaging a plurality of available statistical data, it can be assumed that the clinical manifestations of BPH are found on average in men 50-59 years at 15%, 60-69 years – 60%, 70-79 years – 70%, 80 years and older – 80% . A retrospective analysis shows that up to 30% of men age of forty, living up to 80 years, operated on for BPH.
A study of the results of applying the usual α-blockers in patients with BPH began in 1976. It has been found that prolonged use of these drugs in the initial stages of BPH can achieve 70% of the effect. But these drugs were originally created as a hypotensive, lowering blood pressure. As a result, their application in BPH stopped because of the frequent occurrence of adverse reactions from the cardiovascular system, observed in 30% of patients.
Currently in clinical practice in the treatment of BPH patients successfully used selective α1-AB, such as alfuzosin, doxazosin, terazosin, and α1-blockers (tamsulosin). Without going into the details of the comparative analysis of these drugs, it is necessary to underline that all of them have substantially the same clinical effects with a comparable amount of side reactions, except tamsulosin which shows fewer side effects associated with decreased blood pressure. Most of these drugs produced by different pharmaceutical companies under their own brand names. Therefore, first understand how these drugs, and then move on to specific names.